Literature DB >> 19307742

Modulation of glycine receptor function by the synthetic cannabinoid HU210.

Reyhan Demir1, Martin Leuwer, Jeanne de la Roche, Klaus Krampfl, Nilufar Foadi, Matthias Karst, Reinhard Dengler, Gertrud Haeseler, Jörg Ahrens.   

Abstract

Loss of inhibitory synaptic transmission within the dorsal horn of the spinal cord plays a key role in the development of chronic pain following inflammation or nerve injury. Inhibitory postsynaptic transmission in the adult spinal cord involves mainly glycine. HU210 is a non-psychotropic, synthetic cannabinoid. As we hypothesized that non-CB receptor mechanisms of HU210 might contribute to its anti-inflammatory and anti-nociceptive effects we investigated the interaction of HU210 with strychnine-sensitive alpha(1 )glycine receptors by using the whole-cell patch clamp technique. HU210 showed a positive allosteric modulating effect in a low micromolar concentration range (EC(50): 5.1 +/- 2.6 micromol/l). Direct activation of glycine receptors was observed at higher concentrations above 100 micromol/l (EC(50): 188.7 +/- 46.2 micromol/l). These in vitro results suggest that strychnine-sensitive glycine receptors may be a target for HU210 mediating some of its anti-inflammatory and anti-nociceptive properties. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19307742     DOI: 10.1159/000209291

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  9 in total

Review 1.  Synthetic Pot: Not Your Grandfather's Marijuana.

Authors:  Benjamin M Ford; Sherrica Tai; William E Fantegrossi; Paul L Prather
Journal:  Trends Pharmacol Sci       Date:  2017-02-02       Impact factor: 14.819

2.  Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia.

Authors:  Wei Xiong; Kejun Cheng; Tanxing Cui; Grzegorz Godlewski; Kenner C Rice; Yan Xu; Li Zhang
Journal:  Nat Chem Biol       Date:  2011-04-03       Impact factor: 15.040

Review 3.  Molecular Targets of the Phytocannabinoids: A Complex Picture.

Authors:  Paula Morales; Dow P Hurst; Patricia H Reggio
Journal:  Prog Chem Org Nat Prod       Date:  2017

Review 4.  Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists.

Authors:  R G Pertwee
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

5.  The synthetic cannabinoid dehydroxylcannabidiol restores the function of a major GABAA receptor isoform in a cell model of hyperekplexia.

Authors:  Guichang Zou; Jing Xia; Qianqian Han; Dan Liu; Wei Xiong
Journal:  J Biol Chem       Date:  2019-11-22       Impact factor: 5.157

6.  Comprehensive RNA-Seq expression analysis of sensory ganglia with a focus on ion channels and GPCRs in Trigeminal ganglia.

Authors:  Stavros Manteniotis; Ramona Lehmann; Caroline Flegel; Felix Vogel; Adrian Hofreuter; Benjamin S P Schreiner; Janine Altmüller; Christian Becker; Nicole Schöbel; Hanns Hatt; Günter Gisselmann
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

7.  Structural basis for cannabinoid-induced potentiation of alpha1-glycine receptors in lipid nanodiscs.

Authors:  Arvind Kumar; Kayla Kindig; Shanlin Rao; Afroditi-Maria Zaki; Sandip Basak; Mark S P Sansom; Philip C Biggin; Sudha Chakrapani
Journal:  Nat Commun       Date:  2022-08-18       Impact factor: 17.694

8.  Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors.

Authors:  Wei Xiong; Tanxing Cui; Kejun Cheng; Fei Yang; Shao-Rui Chen; Dan Willenbring; Yun Guan; Hui-Lin Pan; Ke Ren; Yan Xu; Li Zhang
Journal:  J Exp Med       Date:  2012-05-14       Impact factor: 14.307

9.  The Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.